Research Article
Prolonged ICU Stay in Severe and Critically-Ill COVID-19 Patients Who Received Convalescent Plasma Therapy
Table 3
Multivariate analysis on factors confounding mortality.
| | aOR1 | 95% CI | -value |
| Convalescent plasma | 0.45 | 0.12–1.6 | 0.22 | Age | 2.25 | 0.59–8.46 | 0.23 | Hypertension | 1.17 | 0.34–4.01 | 0.80 | Obesity | 14.1 | 1.25–166.7 | 0.032 | Mechanical ventilation on admission | 0.5 | 0.13–1.96 | 0.32 | Mechanical ventilation during ICU stay | 333 | 4.5–1,000 | <0.001 | WBC2 count | 1.87 | 0.47–7.25 | 0.37 | Neutrophil to lymphocyte ratio | 7.32 | 1.82–29.4 | 0.005 | PaO2 to FiO2 ratio | 7.70 | 2.04–29.4 | 0.003 | D-dimer | 1.17 | 0.33–4.17 | 0.81 | Creatinine serum | 1.48 | 0.43–5.12 | 0.53 | Random blood glucose | 2.45 | 0.8–7.51 | 0.17 |
|
|
1Reference group of this regression modeling was length of stay of 7 days or more. 2WBC: White blood cells.
|